HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD105 expression in oral capillary hemangiomas and cavernous hemangiomas.

Abstract
Capillary hemangioma (capillary lobular hemangioma) and cavernous hemangioma (venous malformation) are relatively common oral tumors/malformations and are characterized by increased numbers of normal and abnormal blood vessels. However, the causes of these lesions are not well understood. CD105 (endoglin) is predominantly expressed in proliferating blood endothelial cells (ECs). We analyzed expressions of CD105, CD34, von Willebrand factor, Ki-67, cyclooxygenase-2 (COX-2), and vascular endothelial growth factor (VEGF)-A in 31 capillary hemangiomas and 34 cavernous hemangiomas. Staining scores were calculated as the product of the proportion score and intensity score. Morphologically normal oral mucosa specimens (n = 10) were simultaneously evaluated as normal controls. As compared with cavernous hemangiomas and normal controls, capillary hemangiomas had higher staining scores for CD105, VEGF-A, and COX-2. The Ki-67 labeling index was significantly higher in capillary hemangiomas than in cavernous hemangiomas and normal controls (P < 0.01). These findings suggest that the biological characteristics of capillary and cavernous hemangiomas are quite different. The ECs of capillary hemangiomas actively proliferated and were generally regulated by VEGF-A. In contrast, the ECs of cavernous hemangiomas lacked proliferative activity. These results suggest that angiogenesis and vasodilatation of pre-existing blood vessels are important in the development of capillary hemangioma and cavernous hemangioma, respectively.
AuthorsNaoyuki Matsumoto, Motomi Tsuchiya, Shouta Nomoto, Yasuyoshi Matsue, Yohichi Nishikawa, Tsuyoshi Takamura, Hidero Oki, Kazuo Komiyama
JournalJournal of oral science (J Oral Sci) Vol. 57 Issue 1 Pg. 45-53 (Mar 2015) ISSN: 1880-4926 [Electronic] Japan
PMID25807908 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD34
  • Endoglin
  • Ki-67 Antigen
  • Vascular Endothelial Growth Factor A
  • von Willebrand Factor
  • Cyclooxygenase 2
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD34 (metabolism)
  • Child
  • Cyclooxygenase 2 (metabolism)
  • Endoglin (metabolism)
  • Female
  • Hemangioma, Capillary (metabolism)
  • Hemangioma, Cavernous (metabolism)
  • Humans
  • Immunoenzyme Techniques
  • Ki-67 Antigen (metabolism)
  • Male
  • Middle Aged
  • Mouth Neoplasms (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: